Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
Accuray has opened an education center at the new Genolier Innovation Hub in Switzerland, marking the initiation of CyberKnife® S7™ System medical professional training. As the first industry partner at the hub, Accuray offers training on both CyberKnife and Radixact® Radiation Treatment Delivery Systems.
The center provides comprehensive learning experiences with expert instructors and hands-on simulation facilities. Accuray's presence at the hub aims to expand access to advanced training for system users, supporting the company's commitment to improving cancer patient care.
The CyberKnife and Radixact Systems offer complementary clinical applications, designed to deliver precise and accurate treatments while minimizing dose to healthy tissue. These systems include advanced functionality for efficient administration of radiation treatments, even for moving targets, providing options for managing various cancer cases and neurologic disorders.
Accuray ha inaugurato un centro di formazione presso il nuovo Genolier Innovation Hub in Svizzera, segnando l'inizio della formazione per i professionisti medici sul CyberKnife® S7™ System. In quanto primo partner industriale del centro, Accuray offre formazione sia sul CyberKnife che sui Radixact® Radiation Treatment Delivery Systems.
Il centro fornisce esperienze di apprendimento complete con istruttori esperti e strutture di simulazione pratica. La presenza di Accuray al hub mira ad ampliare l'accesso a una formazione avanzata per gli utenti dei sistemi, supportando l'impegno dell'azienda nel migliorare le cure per i pazienti oncologici.
I CyberKnife e Radixact Systems offrono applicazioni cliniche complementari, progettate per fornire trattamenti precisi e accurati riducendo al minimo la dose ai tessuti sani. Questi sistemi includono funzionalità avanzate per una somministrazione efficiente dei trattamenti radioterapici, anche per bersagli in movimento, fornendo opzioni per gestire vari casi di cancro e disturbi neurologici.
Accuray ha abierto un centro de educación en el nuevo Genolier Innovation Hub en Suiza, marcando el inicio de la formación de profesionales médicos en el CyberKnife® S7™ System. Como primer socio industrial en el hub, Accuray ofrece capacitación tanto en CyberKnife como en los Radixact® Radiation Treatment Delivery Systems.
El centro proporciona experiencias de aprendizaje completas con instructores expertos y instalaciones de simulación práctica. La presencia de Accuray en el hub tiene como objetivo ampliar el acceso a capacitación avanzada para los usuarios del sistema, apoyando el compromiso de la empresa de mejorar la atención a los pacientes con cáncer.
Los Sistemas CyberKnife y Radixact ofrecen aplicaciones clínicas complementarias, diseñadas para proporcionar tratamientos precisos y exactos, minimizando la dosis a los tejidos sanos. Estos sistemas incluyen funcionalidades avanzadas para la administración eficiente de tratamientos de radiación, incluso para objetivos en movimiento, ofreciendo opciones para manejar diversos casos de cáncer y trastornos neurológicos.
Accuray는 스위스의 새로운 Genolier Innovation Hub에 교육 센터를 열어 CyberKnife® S7™ System의 의료 전문가 교육을 시작했습니다. Accuray는 이 허브의 최초의 산업 파트너로서 CyberKnife와 Radixact® Radiation Treatment Delivery Systems에 대한 교육을 제공합니다.
이 센터는 전문 강사와 실습 시뮬레이션 시설을 통해 포괄적인 학습 경험을 제공합니다. Accuray의 허브 내 존재는 시스템 사용자에게 고급 교육 접근성을 확대하고, 암 환자 치료 개선에 대한 회사의 헌신을 지원하는 것을 목표로 하고 있습니다.
CyberKnife와 Radixact 시스템은 상호 보완적인 임상 응용 프로그램을 제공하며, 이는 건강한 조직에 대한 방사선량을 최소화하면서 정확하고 정밀한 치료를 제공하도록 설계되었습니다. 이 시스템은 움직이는 대상에 대한 방사선 치료의 효율적인 시행을 위한 고급 기능을 포함하고 있으며, 여러 암 사례 및 신경학적 질환을 관리하기 위한 옵션을 제공합니다.
Accuray a ouvert un centre de formation au nouveau Genolier Innovation Hub en Suisse, marquant le lancement de la formation des professionnels de la santé sur le système CyberKnife® S7™. En tant que premier partenaire industriel du hub, Accuray propose une formation sur le CyberKnife ainsi que sur les Radixact® Radiation Treatment Delivery Systems.
Le centre offre des expériences d'apprentissage complètes avec des formateurs experts et des installations de simulation pratique. La présence d'Accuray au hub vise à élargir l'accès à une formation avancée pour les utilisateurs du système, soutenant ainsi l'engagement de l'entreprise à améliorer les soins aux patients atteints de cancer.
Les Systèmes CyberKnife et Radixact proposent des applications cliniques complémentaires, conçues pour fournir des traitements précis et exacts tout en minimisant la dose de radiation pour les tissus sains. Ces systèmes incluent des fonctionnalités avancées pour une administration efficace des traitements de radiation, même pour des cibles en mouvement, offrant des options pour la gestion de divers cas de cancer et de troubles neurologiques.
Accuray hat ein Ausbildungszentrum im neuen Genolier Innovation Hub in der Schweiz eröffnet, was den Beginn der Ausbildung für medizinische Fachkräfte im CyberKnife® S7™ System markiert. Als erster Industriepartner im Hub bietet Accuray Schulungen sowohl für das CyberKnife als auch für die Radixact® Radiation Treatment Delivery Systems an.
Das Zentrum bietet umfassende Lernerfahrungen mit erfahrenen Dozenten und praktischen Simulationsmöglichkeiten. Die Präsenz von Accuray im Hub zielt darauf ab, den Zugang zu fortgeschrittener Ausbildung für Systemanwender zu erweitern und das Engagement des Unternehmens zur Verbesserung der Patientenversorgung bei Krebs zu unterstützen.
Die CyberKnife- und Radixact-Systeme bieten ergänzende klinische Anwendungen, die darauf ausgelegt sind, präzise und genaue Behandlungen anzubieten und die Dosis für gesundes Gewebe zu minimieren. Diese Systeme verfügen über fortschrittliche Funktionen zur effizienten Durchführung von Bestrahlungsbehandlungen, sogar für bewegliche Ziele, und bieten Optionen zur Behandlung verschiedener Krebsfälle und neurologischer Störungen.
- None.
- None.
- Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care
- New Accuray CyberComm™ tool was used to significantly reduce the CyberKnife® S7™ System's commissioning time and enable product training in Genolier to begin more quickly
A three-day series of events marked the grand opening of the state-of-the-art Genolier Innovation Hub, unique in
Continued Mr. Chalke, "We opened our European education center within the hub to expand access to advanced training to more Accuray CyberKnife and Radixact System users. We are committed to improving the lives of people diagnosed with cancer and this goal is intricately linked to our customers' ability to optimize their use of our systems. The opportunity to easily access training, such as the courses we offer at our center in Genolier, is critical to their success."
The Accuray education center in Genolier was designed from the ground up to provide a comprehensive learning experience. The training curriculum is created to reflect the distinctive needs of the diverse medical professionals involved in the care of patients treated using radiosurgery and radiotherapy. Course attendees have access to expert instructors and hands-on simulation facilities for training and demonstrations of the CyberKnife and Radixact Systems.
The CyberKnife and Radixact Systems have complementary clinical applications with the same goal: to empower customers to deliver the most precise and accurate treatments while still minimizing dose to healthy tissue, helping to reduce the risk of side effects that may impact patients' quality of life. The systems include advanced functionality that make it easier and more efficient to administer extremely precise radiation treatments, even to targets that move, providing the medical care team with options for managing the full spectrum of cancer cases, from routine to complex and initial treatment to retreatment, and neurologic disorders.
About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in
Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited to, expectations related to expectations regarding the Genolier Innovation Hub and the Company's education center located within Genolier; expectations regarding the Company's training curriculum; and expectations regarding the Company's products. These risks and uncertainties include, but are not limited to, the effect of the current global economic environment, including in connection to the COVID-19 pandemic, on the operations of the company and those of its customers and suppliers; the company's ability to achieve widespread market acceptance of its products; the company's ability to develop new products or improve existing products to meet customers' needs; the company's ability to anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands; reliance on third party collaborators, partnerships, strategic alliances and joint ventures; and such other risks identified under the heading "Risk Factors" in the company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on September 19, 2024, and as updated periodically with the company's other filings with the SEC.
Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-celebrates-opening-of-genolier-innovation-hub-in-switzerland-initiation-of-cyberknife-s7-system-medical-professional-training-302262088.html
SOURCE Accuray Incorporated
FAQ
What is the Genolier Innovation Hub and how is Accuray involved?
What training does Accuray offer at its Genolier Innovation Hub center?
How do the CyberKnife and Radixact Systems benefit cancer treatment?
When did Accuray (ARAY) start offering training at the Genolier Innovation Hub?
